Literature DB >> 11589883

Peritubular filtration as cause of severe hypotony after Ahmed valve implantation for glaucoma.

J García-Feijoó1, R Cuiña-Sardiña, C Méndez-Fernández, A Castillo-Gómez, J García-Sánchez.   

Abstract

PURPOSE: To report peritubular filtration as the cause of severe hypotony after Ahmed valve implantation.
METHODS: Interventional case report. In a 65-year-old man with primary open-angle glaucoma, ultrasound biomicroscopy was used to image the peritubular region of his right eye that had severe hypotony during the early postoperative period after an Ahmed valve implantation.
RESULTS: The ultrasound biomicroscopy examination showed peritubular filtration. Additional surgery consisting of tube extraction, closure of the previous insertion opening, reformation of the anterior chamber with viscoelastic, and reintroduction of the tube through a new paracentesis was performed to solve this complication. Twenty-four hours postoperatively, the intraocular pressure increased to 10 mm Hg. During the 6-month follow-up, the mean intraocular pressure was 16.36 mm Hg (standard deviation, 1.45).
CONCLUSION: The possibility of peritubular filtration should be considered in eyes with severe hypotony after restrictive valve implantation.

Entities:  

Mesh:

Year:  2001        PMID: 11589883     DOI: 10.1016/s0002-9394(01)01057-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  The efficacy of Ahmed glaucoma valve drainage devices in cases of adult refractory glaucoma in Indian eyes.

Authors:  Jitendra K S Parihar; Devendra P Vats; Rakesh Maggon; Vijay Mathur; Anirudh Singh; Sanjay K Mishra
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

2.  Assessment of Filtration Bleb and Endplate Positioning Using Magnetic Resonance Imaging in Eyes Implanted with Long-Tube Glaucoma Drainage Devices.

Authors:  Ichiya Sano; Masaki Tanito; Koji Uchida; Takashi Katsube; Hajime Kitagaki; Akihiro Ohira
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.